Updated: 25-Sep-26 09:43 ET
Co: ADRX
ADARx Pharmaceuticals (Nasdaq) | Late-stage biotech company developing next-generation siRNA therapies designed to selectively silence disease-driving genes and treat a range of chronic diseases | Initial Shares: 21.9 M | Initial Range: $15.00-$17.00 | Priced On: 25-Sep-26, $17.00 | Opened: NA | Underwriters: Lead: JP Morgan, Morgan Stanley, TD Cowen, UBS Investment Bank, and LifeSci Capital
There are no IPOs scheduled for this time period.
Co: ACCV
Accelevation Holdings (Nasdaq) | Provides customized infrastructure systems for mission-critical facilities | Initial Shares: 30.0 M | Initial Range: $20.00-$24.00 | Priced On: NA | Opened: NA | Underwriters: Lead: Morgan Stanley and J.P. Morgan
Co: OURA
ŌURA (Nasdaq) | Health technology company that develops smart rings and a digital health platform to continuously track and analyze sleep, activity, stress, heart health and other wellness metrics | Initial Shares: 50.0 M | Initial Range: $40.00-$44.00 | Priced On: NA | Opened: NA | Underwriters: Lead: Goldman Sachs & Co. LLC, Morgan Stanley, J.P. Morgan, Allen & Company LLC, and Jefferies
There are no IPOs scheduled for this time period.
There are no IPOs scheduled for this time period.